GDRX (goodrx.com) Accounting Capitalization

Official company branding of GoodRx (GDRX)

The daily price chart for GoodRx Holdings, Inc. (GDRX) reflects the performance of a company whose business relies on a high-load cloud-based medication cost monitoring system with optimized servers. The current metric stands at 0.20. Competitiveness is driven by exclusive relationships with PBMs and lobbying efforts, despite strict HIPAA regulations. However, revenue losses are possible due to the renegotiation of terms with pharmacy chains or shifts in pricing principles.

GDRX GoodRx Inc: Company Net Assets in the range 07/04/2022 - 10/30/2026

GDRX (GoodRx): analytical breakdowns and indicator data

- current price and projected stock value:
Price Performance Chart GoodRx Gold|GDRX - Consensus Target
- business market valuation indicators:
Market Capitalization GoodRx Inc|GDRX - Enterprise Value
- book capitalization indicators:
Net Assets per Share GoodRx|GDRX - Company Net Assets|Market Cap to Book Value Multiple goodrx.com|GDRX - Cumulative Company Assets
- company total debt and liquidity indicators:
All Debt to Shareholders' Equity Ratio GoodRx Holdings, Inc.|GDRX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio GoodRx Inc|GDRX - Company Aggregate Debts|Debts to Book Value GoodRx Inc|GDRX - Company Long-Term Debts|Company Short-Term Indebtedness GoodRx|Critical Liquidity goodrx.com
- business earnings and investment ratios data:
GDRX - Company Net Income
Fundamental company valuation:GDRX, GoodRx Gold
Product sample of GoodRx Corp

GoodRx Holdings, Inc. (GDRX) maintains its status as a key medication cost optimization service due to high user trust. Book capitalization reflects the net asset value of the business minus all liabilities. This metric allows for an assessment of the company's real asset foundation, separating intrinsic value from market volatility. Stable capital confirms the brand's resilience amid industry conflicts. By analyzing the volatility of book capitalization, an investor determines the pace of resource accumulation or the risk of asset depreciation.

Competitor analysis for GoodRx Holdings, Inc.

Accounting Value of Company VEEV (Veeva Corp)|DOCS (Doximity, Inc.) - Company Net Assets|Accounting Capitalization HQY|WAY (Waystar) - Book Capitalization|CorVel Corp (CRVL) - Book Valuation of Business|Company Net Assets PRVA (Privia Health Corp)|Total Net Assets HURN|Certara, Inc. - Company Net Assets|Accounting Value of Company OMCL|SDGR - Company Book Value|Phreesia Inc (PHR) - Company Net Assets|OMDA: Book Capitalization|Total Stockholders' Equity Evolent Corp (EVH)|HSTM (HealthStream, Inc.) - Book Capitalization|Accounting Capitalization DH (definitivehc.com)|Book Capitalization CCSI|agilon health, inc. (AGL) - Book Value of Business|Company Book Value Absci Corp. ABSI|So-Young Corp (SY) - Total Stockholders' Equity|NRC - Company Book Value|Total Stockholders' Equity spok.com|OPRX: Book Capitalization|Accounting Capitalization TBRG|Company Book Value Simulations Plus Corp|SOPH: Accounting Value of Company|Company Net Assets HCAT (Health Catalyst, Inc.)|carecloud.com - Accounting Capitalization|Research Solutions - Company Net Assets|Accounting Value of Company DLHC|OneMedNet Corp. - Book Capitalization|Accounting Value of Company SCNX (Scienture Corp)|Healthcare Triangle (HCTI) - Company Book Value|Total Stockholders' Equity iSpecimen (ISPC)|Company Book Value Bullfrog AI Holdings, Inc.|Company Book Value WORX|Book Capitalization MSPR|icoreconnect.com - Accounting Capitalization|Book Capitalization MEDS (TRxADE HEALTH, Inc.)|Book Valuation of Business orgenesis.com (ORGS)|RCM - Company Book Value|SHCR (Sharecare Inc.) - Accounting Capitalization|STRM: Book Capitalization|Book Value of Business Syra Health, Corp. SYRA|Company Book Value Apollo Medical Holdings Inc.|modeln.com (MODN) - Book Valuation of Business|Company Net Assets NXGN (NextGen Healthcare, Inc.)